In the early detection of Alzheimer’s disease, amyloid-based biomarkers in the CSF may be superior to NfL, but in serum and plasma-based diagnostics, serial NfL measurement is particularly advantageous in the early detection of dementia [34]. This evidence concerns the gene NEFL and dementia.